Resolution: Agilent's Acquisition Of Resolution Bioscience
Freshfields advised Agilent (NYSE: A) on its acquisition of Resolution Bioscience. The combination brings together Resolution Bioscience's noninvasive liquid biopsy platform that improves cancer diagnostics with [...]
Read full article »
Resolution is a Washington-based biotech platform that provides solutions such as genetic alteration detection and clinical analysis for the healthcare industry.
Read more